Literature DB >> 21355852

Mitochondrial protection by the thioredoxin-2 and glutathione systems in an in vitro endothelial model of sepsis.

Damon A Lowes1, Helen F Galley.   

Abstract

Oxidative stress and mitochondrial dysfunction are common features in patients with sepsis and organ failure. Within mitochondria, superoxide is converted into hydrogen peroxide by MnSOD (manganese-containing superoxide dismutase), which is then detoxified by either the mGSH (mitochondrial glutathione) system, using the enzymes mGPx-1 (mitochondrial glutathione peroxidase-1), GRD (glutathione reductase) and mGSH, or the TRX-2 (thioredoxin-2) system, which uses the enzymes PRX-3 (peroxiredoxin-3) and TRX-2R (thioredoxin reductase-2) and TRX-2. In the present paper we investigated the relative contribution of these two systems, using selective inhibitors, in relation to mitochondrial dysfunction in endothelial cells cultured with LPS (lipopolysaccharide) and PepG (peptidoglycan). Specific inhibition of both the TRX-2 and mGSH systems increased the intracellular total radical production (P<0.05) and reduced mitochondrial membrane potentials (P<0.05). Inhibition of the TRX-2 system, but not mGSH, resulted in lower ATP production (P<0.001) with high metabolic activity (P<0.001), low oxygen consumption (P<0.001) and increased lactate production (P<0.001) and caspase 3/7 activation (P<0.05). Collectively these results show that the TRX-2 system appears to have a more important role in preventing mitochondrial dysfunction than the mGSH system in endothelial cells under conditions that mimic a septic insult.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21355852     DOI: 10.1042/BJ20102135

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  7 in total

1.  Thidoredxin-2 overexpression fails to rescue chronic high calorie diet induced hippocampal dysfunction.

Authors:  Yong Liu; Ying Yang; Hui Dong; Roy G Cutler; Randy Strong; Mark P Mattson
Journal:  Exp Neurol       Date:  2015-10-22       Impact factor: 5.330

Review 2.  The role of the thioredoxin/thioredoxin reductase system in the metabolic syndrome: towards a possible prognostic marker?

Authors:  Alexey A Tinkov; Geir Bjørklund; Anatoly V Skalny; Arne Holmgren; Margarita G Skalnaya; Salvatore Chirumbolo; Jan Aaseth
Journal:  Cell Mol Life Sci       Date:  2018-01-11       Impact factor: 9.261

3.  Peroxisome proliferator-activated receptor γ co-activator 1-α as a critical co-activator of the murine hepatic oxidative stress response and mitochondrial biogenesis in Staphylococcus aureus sepsis.

Authors:  Anne D Cherry; Hagir B Suliman; Raquel R Bartz; Claude A Piantadosi
Journal:  J Biol Chem       Date:  2013-11-19       Impact factor: 5.157

4.  Intramyocardial injection of thioredoxin 2-expressing lentivirus alleviates myocardial ischemia-reperfusion injury in rats.

Authors:  Yanyan Li; Yin Xiang; Song Zhang; Yan Wang; Jie Yang; Wei Liu; Fengtai Xue
Journal:  Am J Transl Res       Date:  2017-10-15       Impact factor: 4.060

5.  Mitochondrial GSH determines the toxic or therapeutic potential of superoxide scavenging in steatohepatitis.

Authors:  Claudia von Montfort; Núria Matias; Anna Fernandez; Raquel Fucho; Laura Conde de la Rosa; Maria Luz Martinez-Chantar; José M Mato; Keigo Machida; Hidekazu Tsukamoto; Michael P Murphy; Abdellah Mansouri; Neil Kaplowitz; Carmen Garcia-Ruiz; Jose C Fernandez-Checa
Journal:  J Hepatol       Date:  2012-06-09       Impact factor: 25.083

6.  Brain-Derived Neurotrophic Factor Attenuates Septic Myocardial Dysfunction via eNOS/NO Pathway in Rats.

Authors:  Ni Zeng; Junmei Xu; Weifeng Yao; Suobei Li; Wei Ruan; Feng Xiao
Journal:  Oxid Med Cell Longev       Date:  2017-07-09       Impact factor: 6.543

7.  Defective Expression of the Mitochondrial-tRNA Modifying Enzyme GTPBP3 Triggers AMPK-Mediated Adaptive Responses Involving Complex I Assembly Factors, Uncoupling Protein 2, and the Mitochondrial Pyruvate Carrier.

Authors:  Ana Martínez-Zamora; Salvador Meseguer; Juan M Esteve; Magda Villarroya; Carmen Aguado; J Antonio Enríquez; Erwin Knecht; M-Eugenia Armengod
Journal:  PLoS One       Date:  2015-12-07       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.